People | August 16, 2023
BioNTech appointing James Ryan as Chief Legal Officer
Ryan has nearly 20 years of global legal and IP expertise in the pharmaceutical industry
Ryan has nearly 20 years of global legal and IP expertise in the pharmaceutical industry
Proposed acquisition represents meaningful step forward in Biogen’s strategy for sustainable growth
Takes over the commercialization of Biosimilars Business from Viatris in 70+ countries
The transaction represents an enterprise value of €275 million, an estimated 2023 EV/EBITDA multiple of 18x
Lupin has received US$ 25 million from AbbVie for initiation of Phase 1 clinical studies successfully
Under the terms of the collaboration, Vertex and Lonza will partner in the process development and scale-up for the manufacturing of the product portfolio and co-invest to build a dedicated new facility in Portsmouth, New Hampshire (US)
This trial is a multi-national, phase 2/3, open-label, randomized, controlled clinical study of utidelone injectable
Cullgen will have the option during the initial stages of clinical development to participate equally in the costs, profits and losses
Investment enables development of revolutionary multi-omic platform using super-resolution imaging technology for earlier disease detection and accelerated discovery of therapeutics
Sun Pharma will have exclusive rights to commercialise Nidlegy for indications of skin cancers in the territories of Europe, Australia and New Zealand. Philogen will complete pivotal clinical trials for the product in Europe
Subscribe To Our Newsletter & Stay Updated
